DE60121032D1 - Heterocyclische sulfonamide als inhibitoren der beta-amyloid-produktion - Google Patents

Heterocyclische sulfonamide als inhibitoren der beta-amyloid-produktion

Info

Publication number
DE60121032D1
DE60121032D1 DE60121032T DE60121032T DE60121032D1 DE 60121032 D1 DE60121032 D1 DE 60121032D1 DE 60121032 T DE60121032 T DE 60121032T DE 60121032 T DE60121032 T DE 60121032T DE 60121032 D1 DE60121032 D1 DE 60121032D1
Authority
DE
Germany
Prior art keywords
inhibitors
beta
amyloid production
sulphonamides
heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60121032T
Other languages
English (en)
Other versions
DE60121032T2 (de
Inventor
Anthony Frank Kreft
Derek Cecil Cole
Kevin Roger Woller
Joseph Raymond Stock
George Diamanitis
Dennis Michael Kurbrak
Kristina Martha Kutterer
William Jay Moore
David Scott Casebier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Arqule Inc
Original Assignee
Wyeth LLC
Arqule Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22966854&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60121032(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth LLC, Arqule Inc filed Critical Wyeth LLC
Application granted granted Critical
Publication of DE60121032D1 publication Critical patent/DE60121032D1/de
Publication of DE60121032T2 publication Critical patent/DE60121032T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
DE60121032T 2000-12-13 2001-12-11 Heterocyclische sulfonamide als inhibitoren der beta-amyloid-produktion Expired - Lifetime DE60121032T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25510500P 2000-12-13 2000-12-13
US255105P 2000-12-13
PCT/US2001/048375 WO2002057252A2 (en) 2000-12-13 2001-12-11 Heterocyclic sulfonamide inhibitors of beta amyloid production

Publications (2)

Publication Number Publication Date
DE60121032D1 true DE60121032D1 (de) 2006-08-03
DE60121032T2 DE60121032T2 (de) 2007-01-11

Family

ID=22966854

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60121032T Expired - Lifetime DE60121032T2 (de) 2000-12-13 2001-12-11 Heterocyclische sulfonamide als inhibitoren der beta-amyloid-produktion

Country Status (28)

Country Link
US (5) US6610734B2 (de)
EP (1) EP1341779B1 (de)
JP (2) JP2004517892A (de)
KR (1) KR100869061B1 (de)
CN (2) CN1263750C (de)
AR (1) AR035516A1 (de)
AT (1) ATE330950T1 (de)
AU (1) AU2002245123B2 (de)
BR (1) BR0116063A (de)
CA (1) CA2436526C (de)
CY (1) CY1105441T1 (de)
DE (1) DE60121032T2 (de)
DK (1) DK1341779T3 (de)
EA (1) EA009035B1 (de)
ES (1) ES2267853T3 (de)
HK (1) HK1059619A1 (de)
HU (1) HUP0303857A3 (de)
IL (3) IL156268A0 (de)
MX (1) MXPA03005255A (de)
NO (1) NO328885B1 (de)
NZ (2) NZ538100A (de)
PL (1) PL365950A1 (de)
PT (1) PT1341779E (de)
SG (1) SG128491A1 (de)
SI (1) SI1341779T1 (de)
TW (1) TWI235155B (de)
WO (1) WO2002057252A2 (de)
ZA (1) ZA200304135B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60124684T2 (de) * 2000-03-20 2007-09-13 Merck Sharp & Dohme Ltd., Hoddesdon Sulfonamido-substituierte verbrückte bicycloalkylderivative
CN1263750C (zh) 2000-12-13 2006-07-12 惠氏 β淀粉样蛋白产生的杂环磺酰胺类抑制剂
US6657070B2 (en) 2000-12-13 2003-12-02 Wyeth Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
PL370859A1 (en) 2001-12-11 2005-05-30 Wyeth Process for the synthesis of chirally pure beta-amino-alcohols
BR0311767A (pt) * 2002-06-11 2005-03-08 Wyeth Corp Compostos inibidores de sulfonamida substituìda da produção de beta amilóide, suas composições e usos
US7109217B2 (en) * 2002-11-12 2006-09-19 Merck & Co., Inc. Phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's disease
KR20060002908A (ko) * 2003-03-31 2006-01-09 와이어쓰 베타 아밀로이드 생산 억제제인 플루오로- 및트리플루오로알킬-함유 헤테로사이클릭 설폰아미드 및 이의유도체
US7932271B2 (en) * 2003-06-30 2011-04-26 Daiichi Pharmaceutical Co., Ltd. Heterocyclic methyl sulfone derivative
CN1910158A (zh) 2004-01-16 2007-02-07 惠氏公司 含有氮杂环的β淀粉样蛋白生成的杂环磺酰胺抑制剂
CA2595173A1 (en) 2005-01-18 2006-07-27 Elan Pharmaceuticals, Inc. N-substituted heterocyclic sulfonamides
ES2400287T3 (es) * 2005-03-14 2013-04-08 High Point Pharmaceuticals, Llc Derivados de benzazol, composiciones y procedimientos de uso como inhibidores de beta-secretasa
TW200800959A (en) * 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
GB0602951D0 (en) * 2006-02-14 2006-03-29 Novartis Ag Organic Compounds
AU2007217966A1 (en) * 2006-02-17 2007-08-30 Wyeth Selective N-sulfonylation of 2-amino trifluoroalkyl substituted alcohols
CA2641013A1 (en) * 2006-02-17 2007-08-30 Wyeth Methods for preparing sulfonamide substituted alcohols and intermediates thereof
MX2008013539A (es) * 2006-04-21 2008-10-29 Wyeth Corp Produccion de intermediarios de amino alcohol quiralmente puros, derivados de los mismos, y usos de los mismos.
US7476762B2 (en) * 2006-04-21 2009-01-13 Wyeth Methods for preparing sulfonamide compounds
US7550629B2 (en) * 2006-04-21 2009-06-23 Wyeth Trifluoromethyl-containing phenylsulfonamide beta amyloid inhibitors
TW200808740A (en) * 2006-06-09 2008-02-16 Wyeth Corp Succinate salts of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline and crystalline forms thereof
TW200808741A (en) * 2006-06-09 2008-02-16 Wyeth Corp 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts
TW200811144A (en) * 2006-06-09 2008-03-01 Wyeth Corp Crystalline forms of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline
WO2008059238A1 (en) * 2006-11-17 2008-05-22 Astrazeneca Ab Benzenesulfonamide compounds as edg-1 antagonists useful in the treatment of cancer
EP2099741A2 (de) * 2006-11-21 2009-09-16 University Of Virginia Patent Foundation Hydrindan-analoga mit sphingosin-1-phosphatrezeptoragonistenaktivität
CL2007003410A1 (es) * 2006-11-28 2008-04-11 Wyeth Corp Compuestos derivados de 5-fluoro-8-{4-[4-(6-metoxiquinolin-8-il)piperazin-1-il]piperidin-1-il}quinolina; procedimiento de preparacion; compuestos intermediarios; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de trast
TW200901974A (en) 2007-01-16 2009-01-16 Wyeth Corp Compounds, compositions, and methods of making and using them
EP2121633A2 (de) 2007-02-12 2009-11-25 Merck & Co., Inc. Piperazinderivate zur behandlung von alzheimer-krankheit und verwandten leiden
PE20090810A1 (es) * 2007-07-16 2009-07-20 Wyeth Corp Procesos e intermediarios para la preparacion de compuestos de sulfonamida heterociclica
CA2693959A1 (en) * 2007-07-16 2009-01-22 Wyeth Inhibitors of beta amyloid production
US20090023903A1 (en) * 2007-07-16 2009-01-22 Wyeth Process for the preparation of trifluoroalkyl-phenyl and heterocyclic sulfonamides
EP2489656A1 (de) 2007-12-21 2012-08-22 Ligand Pharmaceuticals Inc. Selektive Androgenrezeptormodulatoren (SARMS) und ihre Verwendung
WO2009089237A1 (en) * 2008-01-11 2009-07-16 Wyeth Compositions containing o-sulfate and o-phosphate containing aryl sulfonamide derivatives useful as beta-amyloid inhibitors
US8461389B2 (en) 2008-04-18 2013-06-11 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals
US8163800B2 (en) 2008-07-28 2012-04-24 Blanchette Rockefeller Neurosciences Institute PKC-activating compounds for the treatment of neurodegenerative diseases
SG181643A1 (en) 2009-12-17 2012-07-30 Merck Patent Gmbh Inhibitors of sphingosine kinase
US9802954B2 (en) 2011-08-24 2017-10-31 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
TR201802211T4 (tr) 2013-01-18 2018-03-21 Cardioxyl Pharmaceuticals Inc Geliştirilmiş terapötik indekse sahip nitroksil vericiler.
CN104370769B (zh) * 2013-08-14 2017-05-31 重庆博腾制药科技股份有限公司 一种制备羟基金刚烷甘氨酸衍生物的方法
US10441567B2 (en) 2014-01-17 2019-10-15 Ligand Pharmaceuticals Incorporated Methods and compositions for modulating hormone levels
US11046668B2 (en) 2016-03-11 2021-06-29 Ohio State Innovation Foundation Small molecule antimicrobials
DE202022106287U1 (de) 2022-11-09 2022-11-21 Ahmad Salawi Eine Methode zur Synthese und biologischen Bewertung von neuen Sulfonamid-Analoga

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US656536A (en) * 1899-12-28 1900-08-21 David Fitzgibbons Boiler.
US3376523A (en) * 1966-12-27 1968-04-02 Univ California Transient-suppressing magnetic transmission line
US5591761A (en) 1993-05-20 1997-01-07 Texas Biotechnology Corporation Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5464853A (en) 1993-05-20 1995-11-07 Immunopharmaceutics, Inc. N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US5571821A (en) 1993-05-20 1996-11-05 Texas Biotechnology Corporation Sulfonamides and derivatives thereof that modulate the activity of endothelin
US5594021A (en) 1993-05-20 1997-01-14 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
US5514691A (en) 1993-05-20 1996-05-07 Immunopharmaceutics, Inc. N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin
EP0510700A3 (en) 1991-04-26 1992-12-16 Takeda Chemical Industries, Ltd. Azole compounds, their production and use
GB9110722D0 (en) 1991-05-17 1991-07-10 Fujisawa Pharmaceutical Co Amine derivatives
US5766846A (en) 1992-07-10 1998-06-16 Athena Neurosciences Methods of screening for compounds which inhibit soluble β-amyloid peptide production
US5968942A (en) * 1992-08-25 1999-10-19 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
JP3599287B2 (ja) * 1993-04-28 2004-12-08 三菱化学株式会社 スルホンアミド誘導体
US6342610B2 (en) * 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6376523B1 (en) 1994-05-20 2002-04-23 Texas Biotechnology Corporation Benzenesulfonamides and the use thereof to modulate the activity of endothelin
NZ264143A (en) 1993-08-09 1996-11-26 Lilly Co Eli Use of an aspartyl protease inhibitor to inhibit beta-amyloid peptide production
US5519040A (en) 1994-04-29 1996-05-21 Allergan Substituted thiazole sulfonamides as antiglaucoma agents
US5561146A (en) * 1994-06-10 1996-10-01 Bristol-Myers Squibb Company Modified guanidino and amidino thrombin inhibitors
US5624937A (en) 1995-03-02 1997-04-29 Eli Lilly And Company Chemical compounds as inhibitors of amyloid beta protein production
EP0761680A3 (de) * 1995-09-12 1999-05-06 Ono Pharmaceutical Co., Ltd. Tetrazolverbindungen mit Interleukin-1beta-konvertierendes Enzym inhibierende Aktivität
JPH09136878A (ja) * 1995-09-12 1997-05-27 Ono Pharmaceut Co Ltd テトラゾール誘導体
ES2293651T3 (es) 1995-11-28 2008-03-16 Cephalon, Inc. Inhibidores de cisteina y serina proteasas derivados de aminoacidos d.
WO1997024340A1 (en) 1995-12-27 1997-07-10 Takeda Chemical Industries, Ltd. Oxazole derivatives, their production and use
JPH09235276A (ja) * 1995-12-27 1997-09-09 Takeda Chem Ind Ltd オキサゾール誘導体、その製造法および用途
US5877193A (en) * 1996-07-19 1999-03-02 Hoffmann-La Roche Inc. Use of N-(4-aryl-thiazol-2-yl)-sulfonamides
AU740263C (en) 1996-07-22 2002-05-16 Monsanto Company Thiol sulfonamide metalloprotease inhibitors
US5703129A (en) 1996-09-30 1997-12-30 Bristol-Myers Squibb Company 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of β-amyloid protein production
BR9713314A (pt) * 1996-10-11 2000-01-25 Warner Lambert Co Inibidores da enzima de conversão interleucina-1beta de ácido aspártico substituìdo com sulfonamida
US5985930A (en) 1996-11-21 1999-11-16 Pasinetti; Giulio M. Treatment of neurodegenerative conditions with nimesulide
HUP0001383A3 (en) 1996-11-22 2001-11-28 Lilly Co Eli N-(aryl/heteroaryl) amino acid derivatives, pharmaceutical compositions comprising same and their use
DE19650196A1 (de) * 1996-12-04 1998-06-10 Bayer Ag Thienylsulfonylamino(thio)carbonylverbindungen
GB9725138D0 (en) * 1997-11-27 1998-01-28 Pharmacia & Upjohn Spa Thiophenesulfonamide compounds
JPH11343279A (ja) 1998-03-16 1999-12-14 Shionogi & Co Ltd スルホンアミド誘導体およびそれらを含有するＴＮＦ―α産生抑制剤
US5981168A (en) 1998-05-15 1999-11-09 The University Of British Columbia Method and composition for modulating amyloidosis
WO1999062880A1 (en) * 1998-06-03 1999-12-09 Gpi Nil Holdings, Inc. N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres
US7410995B1 (en) 1998-08-14 2008-08-12 Gpi Nil Holdings Inc. N-linked sulfonamide of heterocyclic thioesters for vision and memory disorders
US6967196B1 (en) 1999-02-26 2005-11-22 Bristol-Myers Squibb Company Sulfonamide compounds and uses thereof
KR20010113820A (ko) 1999-04-19 2001-12-28 시오노 요시히코 옥사디아졸 고리를 갖는 술폰아미드 유도체
EP1088821A1 (de) * 1999-09-28 2001-04-04 Applied Research Systems ARS Holding N.V. Pharmazeutisch wirksamer Sulfonamid Derivate
EP1088815A1 (de) * 1999-09-28 2001-04-04 Applied Research Systems ARS Holding N.V. Pharmaceutisch Aktive Sulfonyl-Aminosäurederivate
US6503901B1 (en) * 1999-10-08 2003-01-07 Bristol Myers Squibb Pharma Company Amino lactam sulfonamides as inhibitors of Aβ protein production
CN1263750C (zh) 2000-12-13 2006-07-12 惠氏 β淀粉样蛋白产生的杂环磺酰胺类抑制剂
US6657070B2 (en) 2000-12-13 2003-12-02 Wyeth Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
PL370859A1 (en) 2001-12-11 2005-05-30 Wyeth Process for the synthesis of chirally pure beta-amino-alcohols
JP4615861B2 (ja) 2001-12-11 2011-01-19 ワイス・エルエルシー キラル的に純粋なα−アミノ酸およびＮ−スルホニルα−アミノ酸の生産
BR0311767A (pt) 2002-06-11 2005-03-08 Wyeth Corp Compostos inibidores de sulfonamida substituìda da produção de beta amilóide, suas composições e usos
KR20060002908A (ko) * 2003-03-31 2006-01-09 와이어쓰 베타 아밀로이드 생산 억제제인 플루오로- 및트리플루오로알킬-함유 헤테로사이클릭 설폰아미드 및 이의유도체

Also Published As

Publication number Publication date
US20110034513A1 (en) 2011-02-10
EP1341779B1 (de) 2006-06-21
AR035516A1 (es) 2004-06-02
US20020183361A1 (en) 2002-12-05
KR100869061B1 (ko) 2008-11-17
US6878742B2 (en) 2005-04-12
CA2436526C (en) 2010-10-19
DE60121032T2 (de) 2007-01-11
US20100022594A1 (en) 2010-01-28
EA009035B1 (ru) 2007-10-26
CN1503790A (zh) 2004-06-09
IL156268A (en) 2008-04-13
US20050196813A1 (en) 2005-09-08
CY1105441T1 (el) 2010-07-28
NO20032645D0 (no) 2003-06-11
TWI235155B (en) 2005-07-01
PL365950A1 (en) 2005-01-24
HUP0303857A2 (hu) 2004-03-29
MXPA03005255A (es) 2004-10-14
US7842718B2 (en) 2010-11-30
IL156268A0 (en) 2004-01-04
WO2002057252A3 (en) 2002-12-12
HUP0303857A3 (en) 2007-07-30
WO2002057252A2 (en) 2002-07-25
ES2267853T3 (es) 2007-03-16
CA2436526A1 (en) 2002-07-25
HK1059619A1 (en) 2004-07-09
NZ538100A (en) 2006-07-28
BR0116063A (pt) 2004-08-03
US7691884B2 (en) 2010-04-06
CN1263750C (zh) 2006-07-12
ZA200304135B (en) 2004-09-03
NO20032645L (no) 2003-08-05
JP2004517892A (ja) 2004-06-17
US20030229127A1 (en) 2003-12-11
AU2002245123B2 (en) 2007-05-24
NO328885B1 (no) 2010-06-07
PT1341779E (pt) 2006-10-31
EP1341779A2 (de) 2003-09-10
IL188853A0 (en) 2011-08-01
ATE330950T1 (de) 2006-07-15
KR20040018318A (ko) 2004-03-03
JP2010265280A (ja) 2010-11-25
EA200300674A1 (ru) 2004-06-24
DK1341779T3 (da) 2006-10-30
SG128491A1 (en) 2007-01-30
SI1341779T1 (sl) 2006-12-31
US6610734B2 (en) 2003-08-26
CN1800176A (zh) 2006-07-12
NZ526213A (en) 2005-05-27

Similar Documents

Publication Publication Date Title
DE60121032D1 (de) Heterocyclische sulfonamide als inhibitoren der beta-amyloid-produktion
DE60236226D1 (de) Verbesserung der Altersweitsichtigkeit
ATE269327T1 (de) Imidazol-5-yl-2-anilino-pyrimidine als inhibitoren der zellproliferation
DE60020100D1 (de) Dimerverbindungen und als inhibitoren der neuramidinase
AR028567A1 (es) Nuevos derivados de fenil-propargileter
NO20021207L (no) Nye spiroheterocykliske forbindelser nyttige som inhibitorer av cystein proteaser
ATE370938T1 (de) Pro-pharmakon von cox-2-inhibitoren
DE60321324D1 (de) Sulfonylaminoderivate als neue inhibitoren von histondeacetylase
DE60305061D1 (de) 2-pyridonderivate als inhibitoren von neutrophiler elastase
AR028596A1 (es) Nuevos derivados de fenilglicina
ATE382042T1 (de) Sulfonamidderivate als wirkstoff-vorläufer von inhibitoren der aspartyl-protease
DE60110205D1 (de) Nicotinamide benzoanellierte-heterocyclische derivate als selektive inhibitoren der pde4 isoenzyme
PT1086076E (pt) Inibidores de sulfonamida de aspartil protease
NO20013666D0 (no) Peptidyl heterosykliske ketoner nyttige som tryptase inhibitorer
EE200300007A (et) Heterotsüklilised tetrahüdropüridino- või piperidinoderivaadid
DE60021194D1 (de) Phenylpiperazin-derivate als inhibitoren der serotonin-wiederaufnahme
ATE260274T1 (de) Furanonderivate als inhibitoren von cathepsin s
HK1070001A1 (en) Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
DE60004017D1 (de) Heterocyclische benzolsulfonamidderivate als bradykinin antagonisten
ATE430726T1 (de) N-acylamino-benzyletherderivate als selektive inhibitoren der monoaminoxidase b
NO20023956L (no) Priperidin- og piperazinsubstituerte N-hydroksyformamider som inhibitorer av metalloproteinaser
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
DE50115858D1 (de) Heterocyclische aminoalkylpyridinderivate als psychopharmaka
DE60031450D1 (de) Polymorph v von torasemid
ATE299138T1 (de) Mandelatsalze von substituierten tetrazyklischen tetrahydrofuranderivaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition